company

NORWEGIAN MEDICAL CONSULTING AS

3970 LANGESUND

Return on Equity
34,26 %
Current Ratio
3,35
Debt-to-Equity Ratio
0,01
Key figures (NOK)2022
Revenue3 776 000
Net Income541 000
Total Assets2 119 000
Total Equity1 579 000
Income (NOK)2022
Revenue3 776 000
Expenditure3 078 000
Operating Profit697 000
Financial Income1 000
Financial Costs3 000
Financial Balance−2 000
Earnings Before Tax695 000
Tax153 000
Net Income541 000
Balance (NOK)2022
Total Fixed Assets349 000
Total Current Assets1 770 000
Total Assets2 119 000
Total Retained Equity1 549 000
Total Equity1 579 000
Total Long-Term Debt12 000
Total Current Debt529 000
Total Equity and Debt2 119 000
Cash flow (NOK)2022
Sales Income3 776 000
Other Income0
Revenue3 776 000
Cost of Goods Sold74 000
Salary Costs2 254 000
Depreciation122 000
Impairment0
Expenditure3 078 000
Operating Profit697 000
Financial Income1 000
Financial Costs3 000
Financial Balance−2 000
Dividends0
Net Income541 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures315 000
Total Tangible Assets315 000
Total Fiancial Fixed Assets34 000
Total Fixed Assets349 000
Stock0
Total Investments0
Cash, Bank1 139 000
Total Current Assets1 770 000
Total Assets2 119 000
Total Equity1 579 000
Short-Term Group Debt0
Total Long-Term Debt12 000
Creditors−1 000
Unpaid Taxes121 000
Dividends0
Other Current Debt318 000
Total Current Debt529 000
Total Equity and Debt2 119 000
Financial indicators2022
Return on Equity34,26 %
Debt-to-Equity Ratio0,01
Operating Profit Margin18,46 %
Current Ratio3,35
Quick Ratio3,35
Equity Ratio0,75
Gross Profit Margin98,04 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English